Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
, human agency means the practical ability to understand AI-supported decisions, exercise judgement, question outputs and shape how work is organised. Each researcher joins an international cohort, receives
-
seeking to recruit a motivated Postdoctoral Researcher to work in the theory projects within the Centre of Excellence in Quantum Materials (https://www.qmat.fi ). The research will be guided by Professor
-
university, with about 4000 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University
-
the network, human agency means the practical ability to understand AI-supported decisions, exercise judgement, question outputs and shape how work is organised. Each researcher joins an international cohort
-
within its five constituent faculties (Economics, Education, Humanities, Law and Social Sciences). Selection of successful applicants will be on the basis of academic excellence. Job description The main
-
based in any discipline within its five constituent faculties (Economics, Education, Humanities, Law and Social Sciences). Selection of successful applicants will be on the basis of academic excellence
-
of Excellence in Neutron-Star Physics 2026-2033 (https://neutronstars.fi/ ), funded by the Research Council of Finland. The Centre of Excellence status provides us with long-term funding, strong connections
-
by Research Council of Finland and led by Professor Minna Lehtonen. The project investigates the relationship between bilingual language use, language switching in particular, and executive functions
-
Solutions (BISONS) Lab. Our research team aims to contribute toward finding solutions for sustainable futures that can benefit people and nature. We focus on developing new insights on human-nature
-
for a fixed-term position of 12 months with possibility to extension (starting date negotiable). Our research group develops novel therapies for inherited retinal diseases (IRDs), combining human